Batu Biologics Selected to Present at Cavendish Global Health Impact Forum

Forum uniquely brings together leading family offices, their foundations and sovereign wealth fund representatives seeking impact investment, grant-giving, and philanthropy opportunities within health and life sciences

SAN DIEGO--()--Batu Biologics, an immuno-oncology company, announced today it has been selected to present at the Cavendish Global Health Impact Forum taking place February 15th to February 18th at the Breakers in Palm Beach, Florida. The purpose of the Forum is to help family offices and foundations develop and implement their individual pro-social impact investing, grant-giving, and philanthropy programs within health and the life sciences. To accomplish this mission, the Forum showcases presentations and panel discussions by leading family offices, accomplished foundations, research institutions, and private-sector companies engaged in developing innovations with the potential for transformational impact on disease prevention, diagnosis and treatment. A unique gathering of family offices, Cavendish Impact Forums are hosted by leading institutions around the world and take place three times each year.

Michael Moffat, Cavendish co-founder and Chief Executive Officer explains, “The theme of our Palm Beach Forum is a ‘Celebration of Philanthropy, Impact Investing and Innovation that is Changing the World.’ With the help of our expert advisors, we conduct a global search of research institutions and private-sector companies in order to identify organizations that meet the required standard of excellence. The quality and originality of Batu Biologics’ research and scientific insights in tumor angiogenesis positions them to make a major contribution to the treatment of solid tumors.

“We are honored to be selected to present at this unique event, and it is further recognition of our innovative approach to treat several solid tumor indications that severely afflict populations around the world today,” said Samuel C. Wagner, President and CEO of Batu Biologics. “We welcome the chance to interact with many of world’s most accomplished scientists, thought-leaders and generous philanthropic individuals and families who are all dedicated to the common cause of improving the health and lives of people around the world.”

Cavendish Global consists of over 200 leading family offices and foundations from around the world with combined assets of over $260 billion who share a passion for pro-social endeavors within health and the life sciences. The Cavendish Global Health Impact Forum provides family offices with a discrete, peer-to-peer knowledge expansion and relationship building environment, combined with the information and educational resources required by foundations actively seeking to accelerate technological innovation and health access through sustainable philanthropy, grant-making and impact investing. The Forum is also an opportunity for family offices to champion and share information on projects and organizations, which they are passionate about with other family offices from around the world.

About Batu Biologics

Batu Biologics is an immuno-oncology company developing novel gene and cellular based therapies for the treatment of cancer. The company has filed an IND application for its lead therapeutic, ValloVax™, a multivalent therapeutic vaccine for Non Small Cell Lung Cancer targeting several tumor-angiogenesis associated antigens. ValloVax™ has demonstrated strong inhibition of tumor growth in several histologically distinct tumor models, and the company is currently raising funds that will enable the completion of a Phase I clinical study. Batu Biologics maintains research facilities at JLABS, located in the Torrey Pines-area biotech cluster of San Diego.

Further information is available on the company's website, www.batubiologics.com

About Cavendish Global

(http://cavendishglobal.com)

Cavendish Global provides family offices and their foundations with a discrete, peer-to-peer knowledge expansion and relationship building environment, combined with the innovative resources required to help develop and implement their individual pro-social impact investment and philanthropy programs within health and the life sciences. Cavendish Global provides family offices with a number of innovative resources, which includes Cavendish Impact Forums. A unique gathering of leading family offices, Cavendish Impact Forums take place three times each year.

For more information: http://cavendishglobal.com

Contacts

Batu Biologics Inc.
Dimitri Theofilopoulos, J.D.
Chief Operations Officer
Phone: 213-359-3179
Fax: 858-597-7090
dimitri.theo@batubiologics.com
www.batubiologics.com
(No Solicitations)
or
Cavendish Global
Alex Charlton, President
+1-917-576-1435
alex.charlton@cavendishglobal.com

Contacts

Batu Biologics Inc.
Dimitri Theofilopoulos, J.D.
Chief Operations Officer
Phone: 213-359-3179
Fax: 858-597-7090
dimitri.theo@batubiologics.com
www.batubiologics.com
(No Solicitations)
or
Cavendish Global
Alex Charlton, President
+1-917-576-1435
alex.charlton@cavendishglobal.com